# Oruka Therapeutics, Inc.: Form 8-K, filed Nov 14, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 16:56 ET
- Period: 2024-11-14
- Accession: 0001213900-24-098530
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390024098530/ea0221362-8k_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390024098530/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390024098530/ea0221362-8k_oruka.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-098530. Last ingested by Listed: Nov 15, 2026, 02:43 ET. No prices; not investment advice.
